Fluorine F 18 DCFPyL PET/CT in Imaging Patients with Prostate Cancer

This clinical trial studies how well fluorine F 18 DCFPyL positron emission tomography (PET)/computed tomography (CT) works in imaging patients with prostate cancer. A PET scan uses radioactive material such as fluorine F 18 DCFPyL injected into the blood to show the internal workings of the body. A CT scan uses x-rays and a computer to produce a 3-dimensional image of the body. Diagnostic procedures, such as fluorine F 18 DCFPyL PET/CT may help the doctors understand the exact location of the disease.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT02825875.

Trial PhaseNo phase specified

Trial Typediagnostic

Lead OrganizationJohns Hopkins University/Sidney Kimmel Cancer Center

Principal InvestigatorKenneth James Pienta

• Primary IDJ15216
• Secondary IDsNCI-2016-00953, CRMS-62968, IRB00084971
• ClinicalTrials.gov IDNCT02825875